This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
TMO vs. IDXX: Which Stock Is the Better Value Option?
by Zacks Equity Research
TMO vs. IDXX: Which Stock Is the Better Value Option?
What's in Store for Thermo Fisher (TMO) in Q1 Earnings?
by Zacks Equity Research
Strength in Analytical Instrument and Laboratory Products and Services segments are likely to have driven Thermo Fisher's (TMO) first-quarter 2024 performance.
Labcorp's (LH) At-Home Mpox Testing Kit Gets the FDA's EUA Nod
by Zacks Equity Research
Labcorp (LH) receives the FDA's Emergency Use Authorization for the Mpox PCR Test Home Collection Kit.
Waters (WAT) Boosts Waters Operating Segment With HPLC System
by Zacks Equity Research
Waters (WAT) launches Alliance iS Bio HPLC system to improve efficiency across biopharma QC laboratories, boosting its Waters Operating segment.
Charles River (CRL) Forges Collaboration With Ship of Theseus
by Zacks Equity Research
Charles River (CRL) is set to perform plasmid production for Ship of Theseus.
Thermo Fisher (TMO) Launches TSX Universal Series ULT Freezers
by Zacks Equity Research
Thermo Fisher's (TMO) new ENERGY STAR-certified TSX Universal Series ULT Freezers deliver tighter temperature control and faster recovery times.
Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed the most recent trading day at $579.46, moving +1.55% from the previous trading session.
Thermo Fisher Scientific Inc. (TMO) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Thermo Fisher (TMO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Thermo Fisher Scientific (TMO) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) reachead $571.56 at the closing of the latest trading day, reflecting a -1.02% change compared to its last close.
Thermo Fisher (TMO) Debuts a New In-Line Metrology Solution
by Zacks Equity Research
Thermo Fisher's (TMO) new LInspector Edge In-line Mass Profilometer delivers real-time, full-coverage mass loading analysis for battery electrode coating.
Here's Why Investors Should Retain Thermo Fisher (TMO) Stock
by Zacks Equity Research
Strength in end markets and strategic collaborations bode well for Thermo Fisher (TMO).
Thermo Fisher Scientific (TMO) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
In the closing of the recent trading day, Thermo Fisher Scientific (TMO) stood at $579.37, denoting a +1.85% change from the preceding trading day.
Thermo Fisher Scientific (TMO) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) concluded the recent trading session at $568.82, signifying a -0.83% move from its prior day's close.
QIAGEN (QGEN) Partners With IPPA to Raise TB Screening Awareness
by Zacks Equity Research
QIAGEN's (QGEN) collaboration with IPPA follows the updated CDC guidelines for TB screening for immigrants in the United States.
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Thermo Fisher (TMO) Inks Deal to Develop Companion Diagnostics
by Zacks Equity Research
Thermo Fisher's (TMO) new partnership with Bayer AG is likely to help increase the latter's precision cancer therapies.
Thermo Fisher Scientific (TMO) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
In the closing of the recent trading day, Thermo Fisher Scientific (TMO) stood at $580.05, denoting a -0.46% change from the preceding trading day.
The Zacks Analyst Blog Highlights Mastercard, AbbVie, Salesforce, Thermo Fisher Scientific and Mondelez
by Zacks Equity Research
Mastercard, AbbVie, Salesforce, Thermo Fisher Scientific and Mondelez are included in this Analyst Blog.
Top Analyst Reports for Mastercard, AbbVie & Salesforce
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Mastercard Incorporated (MA), AbbVie Inc. (ABBV) and Salesforce, Inc. (CRM).
Thermo Fisher Scientific (TMO) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) reachead $580.05 at the closing of the latest trading day, reflecting a -0.7% change compared to its last close.
Thermo Fisher Scientific Inc. (TMO) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Thermo Fisher (TMO). This makes it worthwhile to examine what the stock has in store.
Thermo Fisher Scientific (TMO) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Thermo Fisher Scientific (TMO) closed at $597.25, marking a -0.36% move from the previous day.
Thermo Fisher (TMO) Unveils CorEvitas Clinical Registry in GPP
by Zacks Equity Research
Thermo Fisher's (TMO) new CorEvitas clinical registry addresses an unmet need for real-world evidence related to the clinical and patient-reported outcomes of patients with GPP.
Why Is Steris (STE) Up 5.8% Since Last Earnings Report?
by Zacks Equity Research
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Edwards Lifesciences (EW) Up 2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.